U.S. Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Fine-needle Aspiration, Core, Surgical, Skin Biopsy/Punch Biopsy), By Application, By Site, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Research Methodology
                   1.2 Research Assumptions
                       1.2.1 Estimates And Forecast Timeline
                   1.3 Research Methodology
                   1.4 Information Procurement
                       1.4.1 Purchased Database
                       1.4.2 Gvr’s Internal Database
                       1.4.3 Secondary Sources
                       1.4.3.1 Primary Research
                       1.4.4 Details Of Primary Research
                   1.5 Information Or Data Analysis
                       1.5.1 Data Analysis Models
                           1.5.1.1 End-Use Landscape Assessment
                           1.5.1.2 Market Origin Assessment
                           1.5.1.3 Oncology Diagnosis: Market Competition Analysis
                   1.6 Market Formulation And Validation
                   1.7 Model Details
                       1.7.1 Commodity Flow Analysis
                           1.7.1.1 Approach 1: Commodity Flow Approach
                           1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
                   1.8 U.S. Market: CAGR Calculation
                   1.9 List of Secondary Sources
                   1.10 List of Primary Sources
                   1.11 Objectives
                       1.11.1 Objective 1
                       1.11.2 Objective 2
                       1.11.3 Objective 3
                       1.11.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Outlook
Chapter 3 Market Variables, Trends, and Scope
                   3.1 Cancer Medical Tourism Within & Outside the U.S.
                   3.2 Market Driver Analysis
                       3.2.1 Advent Of Liquid Biopsy
                       3.2.2 Transition Of Novel Oncology Diagnostics From Bench To Clinics
                       3.2.3 Advancements In Quality And Payment Pertaining To Genetic Cancer Tests
                   3.3 Market Restraint Analysis
                       3.3.1 Risks Associated With Biopsy Procedures
                       3.3.2 Technical And Clinical Challenges
                   3.4 Market Opportunity Analysis
                       3.4.1 Integral Role Of Biopsies In Oncology Companion Diagnostics
                       3.4.2 Increase In The Demand For Biopsies In Translational Research
                   3.5 Market Threat Analysis
                       3.5.1 Risk Associated With Repeat Biopsy Procedures
Chapter 4 Business Environment Analysis
                   4.1 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
                   4.2 Porter’s Five Forces Analysis
Chapter 5 Supply Chain Analysis
                   5.1 Sample Collection (List of Biobanks/Center)
                   5.2 Sample Processing (List of Vendors)
Chapter 6 Cost/Pricing Analysis
                   6.1 Biopsy Cost
                       6.1.1 By Indication
                           6.1.1.1 Typical Biopsy Costs For Patients Not Covered By Health Insurance In The U.S.
                       6.1.2 By Type/Method
                   6.2 Key Factors Influencing The Cost
                   6.3 Costs Of Cancer Management
                       6.3.1 Pharma Versus Diagnostics Price Analysis For Cancer Care
                       6.3.2 U.S. Expenditures For Cancer By Source Of Payment
                           6.3.2.1 Expenditures For Cancer Care By Year & Cancer Site, USD Million, 2010 - 2018
Chapter 7 Reimbursement And Regulatory Analysis
                   7.1 Regulatory Framework: U.S. Cancer Biopsy Market
                   7.2 Reimbursement Framework: U.S. Cancer Biopsy Market
Chapter 8 Challenges/Restraints/Complications Analysis
                   8.1 Challenges/Restraints/Complications Analysis
                       8.1.1 By Site (Organ)
                       8.1.2 By Method
Chapter 9 Cancer Biopsy Product Manufacturers
Chapter 10 Type Business Analysis
                   10.1 U.S. Cancer Biopsy Market: Type Movement Analysis
                   10.2 U.S. Cancer Biopsy Market: Comparative Analysis of Biopsy Type
                   10.3 Fine Needle Aspiration
                   10.4 Core Needle Biopsy (CNB)
                       10.4.1 U.S. Cancer Core Needle Biopsy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                           10.4.1.1 U.S. Cancer Core Needle Biopsy Market Estimates And Forecasts For Pharma Use, 2018 - 2030 (USD Million)
                           10.4.1.2 U.S. Cancer Core Needle Biopsy Market Estimates And Forecasts For Clinical-Use, 2018 - 2030 (USD Million)
                   10.5 Cancer Surgical Biopsy
                       10.5.1 U.S. Cancer Surgical Biopsy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                           10.5.1.1 U.S. Cancer Surgical Biopsy Market Estimates And Forecasts For Pharma Use, 2018 - 2030 (USD Million)
                           10.5.1.2 U.S. Cancer Surgical Biopsy Market Estimates And Forecasts For Clinical-Use, 2018 - 2030 (USD Million)
                   10.6 Skin Biopsy/Punch Biopsy
                       10.6.1 U.S. Cancer Fine Needle Aspiration (Fna) Biopsy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                           10.6.1.1 U.S. Cancer Fine Needle Aspiration (Fna) Biopsy Market Estimates And Forecasts For Pharma Use, 2018 - 2030 (USD Million)
                           10.6.1.2 U.S. Cancer Fine Needle Aspiration (Fna) Biopsy Market Estimates And Forecasts For Clinical-Use, 2018 - 2030 (USD Million)
                           10.6.1.3 U.S. Skin Biopsy/Punch Cancer Biopsy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                           10.6.1.4 U.S. Skin Biopsy/Punch Cancer Biopsy Market Estimates And Forecasts For Pharma Use, 2018 - 2030 (USD Million)
                           10.6.1.5 U.S. Skin Biopsy/Punch Cancer Biopsy Market Estimates And Forecasts For Clinical-Use, 2018 - 2030 (USD Million)
                   10.7 Others
                       10.7.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Other Types, 2018 - 2030 (USD Million)
                           10.7.1.1 U.S. other types cancer biopsy market estimates and forecasts for pharma use, 2018 - 2030 (USD Million)
                           10.7.1.2 U.S. other types cancer biopsy market estimates and forecasts for clinical-use, 2018 - 2030 (USD Million)
Chapter 11 Site (Organ) Business Analysis
                   11.1 Cancer Biopsy Market: Site (Organ) Movement Analysis
                   11.2 Breast
                       11.2.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Breast, 2018 - 2030 (USD Million)
                   11.3 Thyroid
                       11.3.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Thyroid, 2018 - 2030 (USD Million)
                   11.4 Uterus & Cervix
                       11.4.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Uterus & Cervix, 2018 - 2030 (USD Million)
                   11.5 Lung
                       11.5.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Lung, 2018 - 2030 (USD Million)
                   11.6 Prostate
                       11.6.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Prostate, 2018 - 2030 (USD Million)
                   11.7 Bladder
                       11.7.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Bladder, 2018 - 2030 (USD Million)
                   11.8 Kidney
                       11.8.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Kidney, 2018 - 2030 (USD Million)
                   11.9 Liver
                       11.9.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Liver, 2018 - 2030 (USD Million)
                   11.10 Pancreas
                       11.10.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Pancreas, 2018 - 2030 (USD Million)
                   11.11 Other Sites
                       11.11.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Other Sites, 2018 - 2030 (USD Million)
Chapter 12 Application (Cause) Business Analysis
                   12.1 U.S. Cancer Biopsy Market: Application (Cause) Movement Analysis
                   12.2 Screening & Monitoring
                       12.2.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Screening & Monitoring, 2018 - 2030 (USD Million)
                   12.3 Diagnostics
                       12.3.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Diagnostics, 2018 - 2030 (USD Million)
                   12.4 Investigational & Translational Research
                       12.4.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Investigational & Translational Research, 2018 - 2030 (USD Million)
                   12.5 Pharma & Biopharma Discovery & Development
                       12.5.1 U.S. Cancer Biopsy Market Estimates And Forecasts For Pharma & Biopharma Discovery & Development, 2018 - 2030 (USD Million)
Chapter 13 Regional Business Analysis
                   13.1 U.S. Cancer Biopsy Market: Regional Movement Analysis
                   13.2 U.S.
                       13.2.1 U.S. Cancer Biopsy Market, 2018 - 2030 (USD Million)
Chapter 14 Competitive Landscape
                   14.1 Market Participation Categorization
                   14.2 Strategy Framework
                   14.3 Vendor Landscape
                       14.3.1 List Of Key Distributors And Channel Partners
                       14.3.2 Key Customers
                       14.3.2.1 List Of Key Customers
                       14.3.3 Public Companies
                           14.3.3.1 List Of Public Companies
                       14.3.4 Private Companies
                           14.3.4.1 List Of Key Private Companies
                       14.3.5 Emerging Players
                           14.3.5.1 List Of Key Emerging Companies
                   14.4 Major Deals And Strategic Alliances Analysis
                       14.4.1 Mergers And Acquisitions
                       14.4.2 Collaborations And Partnerships
                       14.4.3 New Product Launch
                   14.5 Market Impact Analysis By Key Participants
                       14.5.1 Ansoff Matrix
                       14.5.2 Company/Competition Categorization (Primary & Secondary Market Participants)
Chapter 15 Company Profiles
                   15.1 Company Profiles
                       15.1.1 Bd (Becton, Dickinson And Company)
                           15.1.1.1 Company Overview
                           15.1.1.2 Financial Performance
                           15.1.1.3 Product Benchmarking
                           15.1.1.4 Strategic Initiatives
                       15.1.2 Izi Medical Products
                           15.1.2.1 Company Overview
                           15.1.2.2 Product Benchmarking
                           15.1.2.3 Strategic Initiatives
                       15.1.3 Johnson & Johnson Services, Inc.
                           15.1.3.1 Company Overview
                           15.1.3.2 Depuy Synthes
                               15.1.3.2.1 Company Overview
                           15.1.3.3 Ethicon, Inc.
                               15.1.3.3.1 Company Overview
                           15.1.3.4 Financial Performance
                           15.1.3.5 Product Benchmarking
                       15.1.4 Argon Medical
                           15.1.4.1 Company Overview
                           15.1.4.2 Product Benchmarking
                           15.1.4.3 Cook
                           15.1.4.4 Company Overview
                           15.1.4.5 Product Benchmarking
                       15.1.5 Spectra Medical Devices, Inc.
                           15.1.5.1 Company Overview
                           15.1.5.2 Product Benchmarking
                       15.1.6 Medtronic
                           15.1.6.1 Company Overview
                           15.1.6.2 Financial Performance
                           15.1.6.3 Product Benchmarking
                           15.1.6.4 Strategic Initiatives
                       15.1.7 Boston Scientific Corporation
                           15.1.7.1 Company Overview
                           15.1.7.2 Financial Performance
                           15.1.7.3 Product Benchmarking
                           15.1.7.4 Strategic Initiatives
                       15.1.8 Conmed Corporation
                           15.1.8.1 Company Overview
                           15.1.8.2 Financial Performance
                           15.1.8.3 Product Benchmarking
                       15.1.9 Inrad, Inc.
                           15.1.9.1 Company Overview
                           15.1.9.2 Product Benchmarking
                       15.1.10 Thermo Fisher Scientific, Inc.
                           15.1.10.1 Company Overview
                           15.1.10.2 Financial Performance
                           15.1.10.3 Product Benchmarking
                           15.1.10.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 Reasons for the popularity of oncology tourism in some countries
Table 3 Common types of oncology tourism treatments
Table 4 Liquid biopsy developing or commercializing companies
Table 5 Average pricing analysis: Biopsy to indication
Table 6 Average pricing analysis: Biopsy to indication
Table 7 Expenditures for cancer care by year & cancer site, USD Million, 2010 - 2018
Table 8 List of cleared/approved companion diagnostic devices (In vitro and imaging tools)
Table 9 Types of insurance coverage
Table 10 Policy structure types issued by private payers and Medicare
Table 11 Coverage policies for ctDNA
Table 12 CPT codes for minimally invasive prostate procedures
Table 13 CPT codes for office visits-new & established patient
Table 14 Surgical biopsy: Feasibility analysis across cancer diagnosis
Table 15 Comparative analysis of traditional and liquid liver biopsies

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 End-use landscape: Cancer biopsy product penetration
Fig. 5 Cancer biopsy: Market origin/parent market assessment
Fig. 6 Market competition analysis: Early diagnosis industry sector
Fig. 7 Market formulation & validation
Fig. 8 U.S. cancer biopsy market outlook (2022)
Fig. 9 U.S. cancer biopsy market driver impact
Fig. 10 External factors driving the demand for cancer biopsy
Fig. 11 U.S. cancer biopsy market restraint impact
Fig. 12 SWOT analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Key driving factors of biopsy costs
Fig. 15 U.S. expenditures for cancer by payment source, 2018
Fig. 16 National cancer costs projected to increase drastically by 2030, in USD Billion
Fig. 17 U.S. out-of-pocket expenses 2014 vs. 2018
Fig. 18 U.S. cancer management expenditure
Fig. 19 U.S. cancer biopsy market: Type outlook and key takeaways
Fig. 20 U.S. cancer biopsy market: Type movement analysis
Fig. 21 Tissue biopsy vs liquid biopsy: Comparative analysis
Fig. 22 U.S. cancer core needle biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. cancer core needle biopsy market estimates and forecasts for pharma use, 2018 - 2030 (USD Million)
Fig. 24 U.S. cancer core needle biopsy market estimates and forecasts for clinical-use, 2018 - 2030 (USD Million)
Fig. 25 U.S. cancer surgical biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 U.S. cancer surgical biopsy market estimates and forecasts for pharma use, 2018 - 2030 (USD Million)
Fig. 27 U.S. cancer surgical biopsy market estimates and forecasts for clinical-use, 2018 - 2030 (USD Million)
Fig. 28 U.S. cancer fine needle aspiration (FNA) biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. cancer fine needle aspiration (FNA) biopsy market estimates and forecasts for pharma use, 2018 - 2030 (USD Million)
Fig. 30 U.S. cancer fine needle aspiration (FNA) biopsy market estimates and forecasts for clinical-use, 2018 - 2030 (USD Million)
Fig. 31 U.S. skin biopsy/punch cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 U. S .skin biopsy /punch cancer biopsy market estimates and forecasts for pharma use, 2018 - 2030 (USD Million)
Fig. 33 U.S. skin biopsy /punch cancer biopsy market estimates and forecasts for clinical-use, 2018 - 2030 (USD Million)
Fig. 34 U.S. cancer liquid biopsy market estimates and forecasts for other types, 2018 - 2030 (USD Million)
Fig. 35 U.S. other types of cancer biopsy market estimates and forecasts for pharma use, 2018 - 2030 (USD Million)
Fig. 36 U.S. other types of cancer biopsy market estimates and forecasts for clinical-use, 2018 - 2030 (USD Million)
Fig. 37 Cancer biopsy market: Site (Organ) outlook and key takeaways
Fig. 38 Cancer biopsy market: Site (Organ) movement analysis
Fig. 39 U.S. cancer biopsy market estimates and forecasts for breast, 2018 - 2030 (USD Million)
Fig. 40 U.S. cancer biopsy market estimates and forecasts for thyroid, 2018 - 2030 (USD Million)
Fig. 41 U.S. cancer biopsy market estimates and forecasts for uterus & cervix, 2018 - 2030 (USD Million)
Fig. 42 U.S. cancer biopsy market estimates and forecasts for lung, 2018 - 2030 (USD Million)
Fig. 43 U.S. cancer biopsy market estimates and forecasts for prostate, 2018 - 2030 (USD Million)
Fig. 44 U.S. cancer biopsy market estimates and forecasts for bladder, 2018 - 2030 (USD Million)
Fig. 45 U.S. cancer biopsy market estimates and forecasts for kidney, 2018 - 2030 (USD Million)
Fig. 46 U.S. cancer biopsy market estimates and forecasts for liver, 2018 - 2030 (USD Million)
Fig. 47 U.S. cancer biopsy market estimates and forecasts for pancreas, 2018 - 2030 (USD Million)
Fig. 48 U.S. cancer biopsy market estimates and forecasts for other sites, 2018 - 2030 (USD Million)
Fig. 49 U.S. cancer biopsy market: Application (Cause) outlook and key takeaways
Fig. 50 U.S. cancer biopsy market: Application (Cause) movement analysis
Fig. 51 U.S. cancer biopsy market estimates and forecasts for screening & monitoring, 2018 - 2030 (USD Million)
Fig. 52 U.S. cancer biopsy market estimates and forecasts for diagnostics, 2018 - 2030 (USD Million)
Fig. 53 U.S. cancer biopsy market estimates and forecasts for investigational & translational research, 2018 - 2030 (USD Million)
Fig. 54 U.S. cancer biopsy market estimates and forecasts for pharma & biopharma discovery & development, 2018 - 2030 (USD Million)
Fig. 55 U.S. cancer biopsy market, 2018 - 2030 (USD million)
Fig. 56 Participant categorization - U.S. cancer biopsy market
Fig. 57 Strategy framework - U.S. cancer biopsy market
Fig. 58 Ansoff matrix
Fig. 59 Competition categorization